DJ-1 mediates regulation of metabolism and immune response in Parkinsons disease astrocytes and Glioblastoma cells
Pauline Mencke,Jochen Ohnmacht,Felicia Jeannelle,Adrien J Ries,Monica Miranda de la Maza,Mathilde Ullrich,Francois Massart,Patrycja Mulica,Katja Badanjak,Zoe Hanss,Arkadius Rybicki,Paul Antony,Sylvie Delcambre,Giuseppe Arena,Gerald Cruciani,Javier Jarazo,Floriane Gavotto,Christian Jaeger,Anouk Ewen,Maria Pires Pacheco,Dirk Brenner,Jens Christian Schwamborn,Thomas Sauter,Lasse Sinkkonen,Gunnar Dittmar,David Bouvier,Johannes Meiser,Anne Gruenewald,Vincenzo Bonifati,Michael Platten,Rejko Krueger,Ibrahim Boussaad
DOI: https://doi.org/10.1101/2024.10.31.621212
2024-11-01
Abstract:An inverse correlation for the expression of Parkinsons disease (PD)- and cancer-associated genes has been previously reported. Genes that are upregulated in cancer are frequently downregulated in PD and vice versa. PARK7, encoding DJ-1, was initially identified as an oncogene, but loss of DJ-1 causes early-onset PD. However, it remains elusive how differential DJ-1 levels contribute to opposite cell fates in cancer and PD. Here, we demonstrate specific effects of differential DJ-1 protein levels on the energy metabolism and cell growth in patient-derived cellular models of PD and glioblastoma (GBM) cell lines. Impaired energy metabolism was associated with an increased immune response upon IL-1β stimulation and increased apoptosis and decreased cell growth in models of PD, whereas in GBM cells increased metabolic activity translated into a reduced immune response and increased cell growth. Furthermore, we found decreased glutathione (GSH) synthesis and therefore increased levels of reactive oxygen species (ROS) and oxidized glutathione (GSSG) in models of DJ-1 deficiency and decreased ROS levels in GBM cell lines. Thus, the mechanism by which DJ-1 modulates these phenotypes is the same in both diseases.
Neuroscience